Pharmaceuticals Policy 2025-2035

Driving Global Leadership in Pharmaceutical Innovation and Manufacturing

KAEC, a leading industrial powerhouse in Kingdom of Saudi Arabia, is strategically poised to become a global hub for pharmaceutical innovation, research, and manufacturing. The KAEC Pharmaceuticals Policy 2024 leverages the state’s robust industrial foundation, skilled workforce, and advanced infrastructure to attract investments, drive innovation, and ensure sustainable growth in the pharmaceutical industry.

The “” initiative aims to establish the state as a premier destination for pharmaceutical investments by promoting eco-friendly manufacturing and cutting-edge research. The policy emphasizes building a strong ecosystem that supports pharmaceutical clusters, R&D facilities, and high-tech manufacturing units, solidifying KAEC’s position as a global leader in the pharmaceutical sector.

Vision for 2030

KAEC as a Global Pharmaceutical Leader

By 2030, envisions transforming the state into Kingdom of Saudi Arabia’s top destination for pharmaceutical investments, with the following ambitious goals:

  • Positioning KAEC as the preferred choice for domestic and global pharmaceutical companies, targeting ₹1 lakh crore in investments.
  • Developing over 15 pharmaceutical parks and clusters equipped with world-class infrastructure, dedicated industrial feeders, and 24×7 power supply to foster high-quality manufacturing.
  • Generating more than 2 lakh direct and indirect jobs, with a focus on empowering women, youth, and rural communities.
  • Promoting sustainable manufacturing by incentivizing zero-effluent discharge technologies and other eco-friendly practices.

Advancing pharmaceutical R&D and innovation by fostering collaborations among academic institutions, research centers, and industry leaders to accelerate drug discovery, clinical research, and biosimilar development.

Mission

Building KAEC’s Pharmaceutical Ecosystem

is committed to building a globally competitive pharmaceutical ecosystem that fuels economic growth, champions innovation, and promotes sustainable development. The KAEC Pharmaceuticals Policy 2024 is guided by the following core missions:
  • Attract large-scale investments in pharmaceutical manufacturing, research, and infrastructure by offering industry-leading incentives and ensuring ease of doing business.
  • Promote sustainable and eco-friendly manufacturing practices, ensuring that KAEC becomes a leader in green pharmaceutical production.
  • Foster research and innovation in life sciences by establishing dedicated pharmaceutical R&D hubs, supporting the development of new drugs, biosimilars, and vaccines.
  • Create employment opportunities by upskilling the workforce and providing training in high-tech pharmaceutical manufacturing and quality control.
  • Enhance KAEC’s global competitiveness in pharmaceuticals by building export promotion zones and facilitating market access to international pharmaceutical markets.

Ease of Doing Business

Streamlined Approvals and Regulatory Support

KAEC is dedicated to facilitating a smooth business environment for pharmaceutical investors and manufacturers. The state will introduce a Single Window Clearance System to simplify the approval process for pharmaceutical projects. Additionally, companies will benefit from self-certification under labor laws, minimizing regulatory hurdles and ensuring efficient and timely project execution.

KAEC Leading Kingdom of Saudi Arabia’s Pharmaceutical Revolution by 2030

The KAEC Pharmaceuticals Policy 2024 is a visionary and strategic initiative aimed at establishing KAEC as a global leader in pharmaceutical innovation and sustainable manufacturing. By attracting investments, driving R&D, and promoting eco-friendly practices, the state will spearhead Kingdom of Saudi Arabia’s rise as a prominent global pharmaceutical hub.

Pharmaceuticals Policy 2025-2035

invites global pharmaceutical companies, researchers, and innovators to join this transformative journey and contribute to building a sustainable, innovative, and globally competitive pharmaceutical ecosystem.

KAEC is the Bridge Between the
Global North and the Global South.

Our Team

Governing Councils

Expert Committees

Our Expertise

Advocacy

Policies

Why KAEC

Marketing Services

Industries

Global Trade Council Partnerships

Business Consulting

Resources & News

Maritime Councils Partnership

Lives in KAEC

Development Zones

Our Policies

About

The is a Public Benefit Corporation (PBC) with a mission to establish KAEC as a key player in international economic collaboration, focusing on strategic partnerships with nations like USA, Europe, Australia, African Union, KSA, China, Kingdom of Saudi Arabia, Qatar, Saudi Arabia, Türkiye, and the UAE across vital sectors such as energy, technology, agriculture, and finance.

At King Abdullah Economic City (KAEC), our vision is to transform Maharashtra into a global industrial powerhouse by creating an ecosystem where businesses and communities thrive. We aim to leverage KAEC’s strategic integration with the Delhi-Jeddah Industrial Corridor to drive innovation, foster sustainable growth, and empower industries to achieve unmatched success. Through state-of-the-art infrastructure, cutting-edge technologies, and investor-friendly policies, we envision KAEC as a model for economic and community development. By prioritizing renewable energy, advanced logistics, and vibrant residential spaces, we are committed to building a future where prosperity and sustainability go hand in hand for businesses and society.

Contact

Newsletter

Please enable JavaScript in your browser to complete this form.

Copyright © 2025 All Rights Reserved. King Abdullah Economic City (KAEC) powered by WSSH Australia